Brickman, A S <br/><br/>
1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.  [electronic resource] 

 -  Archives of internal medicine  Nov 1974 
 - 883-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0003-9926 
<br/><br/><label>Standard No.: </label>10.1001/archinte.134.5.883  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens<br/>Biopsy<br/>Calcium--blood<br/>Chronic Kidney Disease-Mineral and Bone Disorder--drug therapy<br/>Clinical Trials as Topic<br/>Dihydroxycholecalciferols--adverse effects<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Hydroxycholecalciferols--therapeutic use<br/>Hypercalcemia--chemically induced<br/>Hyperparathyroidism, Secondary--drug therapy<br/>Ilium--pathology<br/>Male<br/>Middle Aged<br/>Osteomalacia--drug therapy<br/>Parathyroid Hormone--blood<br/>Phosphorus--blood